Beat Childhood Cancer Specimen Banking and Data Registry
Launched by GISELLE SHOLLER · Jan 15, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Beat Childhood Cancer Specimen Banking and Data Registry is a research study aimed at understanding pediatric cancer better. This trial involves collecting samples and information from children and adolescents who have been diagnosed with suspected or confirmed tumors. The goal is to build a valuable database that can help researchers learn more about childhood cancers and potentially improve future treatments.
Anyone, regardless of age, who has a suspected or confirmed pediatric tumor may be eligible to participate. To join, patients or their legal guardians need to provide consent for the collection of samples and data. If you decide to participate, you can expect to provide some samples, like blood or tissue, and answer questions about your health. Your involvement will contribute to important research that could benefit others facing similar challenges in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • No age restrictions
- * Subjects that fit into one of the following categories:
- • 1. Subjects with suspected or confirmed cancers of childhood, adolescence, or young adulthood.
- • 2. Survivors of a cancer of childhood, adolescence, or young adulthood (\> 6 months off last therapy for cancer)
- • 3. Subjects with a disease-matched condition
- • 4. Healthy volunteers- including any participants with medical conditions that are not disease-matched.
- • Written informed consent in accordance with institutional and FDA guidelines must be obtained from all subjects (or subjects' legal representative).
- Exclusion Criteria:
- • Subject or his/her legally authorized representative (where applicable) did not consent for specimen banking and data collection for this study.
About Giselle Sholler
Giselle Sholler is a dedicated clinical trial sponsor renowned for her commitment to advancing innovative therapies in oncology, particularly for pediatric and rare cancers. With a robust background in clinical research and a passion for improving patient outcomes, she leads initiatives that emphasize collaboration among researchers, healthcare professionals, and patient advocacy groups. Under her guidance, clinical trials are designed with a patient-centric approach, ensuring rigorous adherence to ethical standards and regulatory compliance. Giselle's leadership is characterized by a relentless pursuit of scientific excellence and a deep empathy for the communities she serves, driving forward the mission to bring novel treatments from the lab to the clinic.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Saint Louis, Missouri, United States
Norfolk, Virginia, United States
Winston Salem, North Carolina, United States
Saint Louis, Missouri, United States
Orlando, Florida, United States
Kansas City, Missouri, United States
Little Rock, Arkansas, United States
Louisville, Kentucky, United States
Providence, Rhode Island, United States
Hartford, Connecticut, United States
Charlotte, North Carolina, United States
Hershey, Pennsylvania, United States
Portland, Oregon, United States
Austin, Texas, United States
Tampa, Florida, United States
Patients applied
Trial Officials
Giselle Sholler, MD
Study Chair
Beat Childhood Cancer at Atrium Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials